Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Feb 15, 2018

Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company reported revenue for Q4 of $2.1 million, doubling revenue for the year, and signed agreements for 337 instruments. Contracts for customer evaluations...Read more

Feb 8, 2018

Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will review financial resul...Read more

Jan 10, 2018

Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4
TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its latest assay for the Accelerate Pheno™ system targeting severe bacterial pneumonia infections. During the related study, results for the severe ...Read more

Jan 4, 2018

Accelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco
TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place Wednesday, January 10, 2018 at 10:30 AM, Pacific Time. A live w...Read more

Nov 27, 2017

Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency
TUCSON, Ariz., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. has teamed up with Sepsis Alliance for #GivingTuesday, November 28th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide. Accelerate Diagnostics ha...Read more

Nov 16, 2017

Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
TUCSON, Ariz., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Charles Watts, M.D. to the company's board of directors. His appointment is effective November 14, 2017. Dr. Watts has held a number of clinical and administrative leadership positions at two renowned academic medical centers, Northw...Read more

Nov 15, 2017

Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City
TUCSON, Ariz., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 28, 2017, at 10:00 AM Eastern Time. A live webcast of the presentation will be accessible fro...Read more

Nov 2, 2017

Accelerate Diagnostics reports Q3 2017 financial results
TUCSON, Ariz., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending September 30, 2017.  The company further reported signed agreements for 295 instruments year to date; contracts for customer evaluations total 239 instruments while revenue generating placements grew t...Read more

Oct 16, 2017

Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd
TUCSON, Ariz., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, November 2, 2017 to review its third quarter 2017 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will...Read more

Sep 13, 2017

Plaintiffs Dismiss Class Action Appeal Against Accelerate Diagnostics
TUCSON, Ariz., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that the United States Court of Appeals for the Ninth Circuit signed an order dismissing the plaintiffs' Appeal of their class action lawsuit filed against Accelerate and certain of its executives. Shortly before the Appeal was scheduled to be argued, t...Read more
1
2
3
...
8
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 24.55
-0.60
(2.39%)
4:00 PM ET on Feb 20, 2018
Day High: 25.25
Day Low:  24.50
Volume:    164,067
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates